Mid-pregnancy serum chemerin levels predict persistence of postpartum hypertension in patients with polycystic ovary syndrome
Clicks: 1
ID: 317563
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #65 of 91 articles by views in european journal of endocrinology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
OBJECTIVE: Polycystic ovary syndrome (PCOS) is associated with a higher incidence of pregnancy-related hypertensive disorders (PHD), and an increased cardiometabolic risk. Chemerin, an adipokine involved in metabolic and inflammatory pathways, has been linked to both PCOS and PHD. This study was designed to test the hypothesis that mid-pregnancy maternal serum chemerin levels may predict persistent hypertension one year after delivery in women with PCOS and a history of PHD. DESIGN: Longitudinal cohort study. METHODS: Ninety-two patients with and without PCOS and previous PHD were studied 12 months after delivery. Serum chemerin concentrations were measured at 20 weeks of gestation. Logistic regression models were used to assess the association between chemerin and persistent hypertension. Receiver operating characteristic curve analysis evaluated predictive performance. RESULTS: Women with persistent hypertension exhibited significantly higher chemerin levels compared with normotensive women (median 31.3 vs. 20.1 ng/mL; P = 0.0003). Chemerin concentrations resulted independently associated with persistent hypertension (adjusted odds ratio 6.66 per 10 ng/mL; 95% CI 2.21-20.07; P = 0.0007). Among women with PCOS, a higher chemerin threshold (∼32.3 ng/mL) provided a positive predictive value of 57.1% and a negative predictive value of 82.9%. CONCLUSIONS: Mid-pregnancy chemerin levels independently predict persistent hypertension after delivery in patients with PCOS and prior PHD.
| Reference Key |
openalex_W7164917036
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Stefano Palomba, Giuseppe Seminara, Flavia Costanzi, Rossella Cannarella, Tiziana Russo, Martina Sarica, Fabrizio Signore, Donatella Caserta, Aldo E Calogero, Antonio Aversa |
| Journal | european journal of endocrinology |
| Year | 2026 |
| DOI |
10.1093/ejendo/lvag102
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.